2026 vertical AI is agent-native and workflow-embedded. I/O Mesh maps each industry wedge to a learning loop on dept.* products, GA/Beta connectors, and LoopCompound™ (Build · Steer · Compound) — not a generic chatbot skin. Start where ops context is densest: SaaS, platform SRE, RevOps, fintech, and healthtech provider success.
Each map uses LoopCompound™ · Build · Steer · Compound and the same Integrations & readiness matrix as the platform page.
Primary wedge: PLG-to-enterprise learning loops across engineering, product, sales, CS, and support — department-owned context without a company-wide vector dump.
Map: 2026 vertical AI spend favors agents embedded in existing SaaS workflows (CRM, tickets, Git, chat) over generic copilots — B2B SaaS has the tool sprawl and multi-dept journeys that reward a shared ops mesh.
AI-SRE-ready context plane: incidents, deploys, and on-call evidence as governed dept.* products — agents that investigate with lineage, not another alert chat box.
Map: 2026 AI SRE category is flooded with alert-correlation agents; durable gains come from agents that reuse change + incident history under governance (context engineering), not one-shot log chat.
Revenue learning loops: pipeline, support burden, and renewal context on one fabric — agents that prep QBRs and forecast narratives from governed facts.
Map: Enterprise agent ROI clusters where revenue workflows already cross CRM, support, and finance systems; 2026 GTM agents fail when they only see the CRM slice.
Dispute, fraud-ops, and finance close loops with traceable evidence chains — owned institutional memory and audit-friendly dept.* products for regulated evaluators.
Map: BFSI remains a top vertical AI budget (ops + compliance). Agents that cannot prove lineage lose RFPs; mesh + FAIR-style product contracts are the differentiator vs chat-only dispute bots.
Care-adjacent CS and support for provider customers — governed escalation and account health with enterprise evaluation paths (HIPAA readiness mapping, not a clinical claims system).
Map: Healthcare leads vertical AI spend, but production wins are in administrative and B2B provider workflows with governance — not unrestricted clinical freelancing agents.